Variant report
Variant | esv3334214 |
---|---|
Chromosome Location | chr3:83481887-83484260 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191170389 | chr3:83481951-83481952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76607508 | chr3:83481971-83481972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs398082244 | chr3:83481977-83481978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577596956 | chr3:83482043-83482044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183437979 | chr3:83482057-83482058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565734968 | chr3:83482134-83482135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540162916 | chr3:83482153-83482154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528100375 | chr3:83482199-83482200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547922657 | chr3:83482215-83482216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568025892 | chr3:83482263-83482264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147222624 | chr3:83482329-83482330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556404598 | chr3:83482383-83482384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575991157 | chr3:83482390-83482391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369545637 | chr3:83482427-83482428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187476730 | chr3:83482459-83482460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371622397 | chr3:83482464-83482465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192278275 | chr3:83482473-83482474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569934571 | chr3:83482497-83482498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538797464 | chr3:83482498-83482499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558632982 | chr3:83482505-83482506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576396896 | chr3:83482534-83482535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138797376 | chr3:83482575-83482576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs541513369 | chr3:83482598-83482599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76075295 | chr3:83482615-83482616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372930365 | chr3:83482633-83482634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574763436 | chr3:83482677-83482678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs369471023 | chr3:83482766-83482767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374493235 | chr3:83482767-83482768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6798686 | chr3:83482774-83482775 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs532350978 | chr3:83482802-83482803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183081386 | chr3:83482805-83482806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559495654 | chr3:83482815-83482816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528200450 | chr3:83482819-83482820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548251011 | chr3:83482821-83482822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs567979818 | chr3:83482877-83482878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111641775 | chr3:83482888-83482889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34934228 | chr3:83482909-83482910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11918079 | chr3:83482911-83482912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577684812 | chr3:83482947-83482948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545355934 | chr3:83482987-83482988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554097419 | chr3:83483022-83483023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550061906 | chr3:83483034-83483035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142807600 | chr3:83483117-83483118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147261547 | chr3:83483159-83483160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35745920 | chr3:83483222-83483223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552402604 | chr3:83483231-83483232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572522212 | chr3:83483238-83483239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534843600 | chr3:83483257-83483258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540795501 | chr3:83483291-83483292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555015145 | chr3:83483337-83483338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Autism | 20808228 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:83480000-83484600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr3:83483200-83485000 | Enhancers | Dnd41 | blood |
3 | chr3:83483600-83484800 | Enhancers | Fetal Brain Female | brain |
4 | chr3:83483600-83485000 | Enhancers | Fetal Brain Male | brain |
5 | chr3:83483800-83484000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr3:83483800-83485200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr3:83484000-83484200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr3:83484000-83484200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr3:83484000-83484200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr3:83484000-83484600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr3:83484000-83484800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr3:83484200-83484400 | Flanking Active TSS | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr3:83484200-83484600 | Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr3:83484200-83484600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr3:83484200-83484600 | Enhancers | Muscle Satellite Cultured Cells | -- |
16 | chr3:83484200-83484800 | Active TSS | A549 | lung |
17 | chr3:83484200-83485200 | Enhancers | Cortex derived primary cultured neurospheres | brain |